Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liesl Grobler

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Cochrane Database of Systematic Reviews|October 29, 2024
Improving adverse drug event reporting by healthcare professionalsGloria Shalviri, Niayesh Mohebbi, Fariba Mirbaha, et al.
The Cochrane Database of Systematic Reviews|September 30, 2025
Dose reduction and discontinuation of conventional synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with rheumatoid arthritis or psoriatic arthritis in remission or low disease activityHuai Leng Pisaniello, Samuel L Whittle, Renea V Johnston, et al.
The Cochrane Database of Systematic Reviews|March 1, 2024
Models for delivery and co-ordination of primary or secondary health care (or both) to older adults living in aged care facilitiesPolina Putrik, Liesl Grobler, Aislinn Lalor, et al.
The Cochrane Database of Systematic Reviews|December 16, 2024
Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with psoriatic arthritis in remission or low disease activityHelen Ramsay, Renea V Johnston, Sheila Cyril, et al.
The Cochrane Database of Systematic Reviews|April 22, 2025
Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancerLiesl Grobler, Denise O'Connor, Danny Rischin, et al.
The Spine Journal : Official Journal of the North American Spine Society|July 10, 2025
Agreement between high-quality clinical practice guidelines in their treatment recommendations for low back pain: a systematic reviewBayden J McKenzie, Romi Haas, Giovanni E Ferreira, et al.
The Cochrane Database of Systematic Reviews|May 20, 2026
Perioperative use of disease-modifying anti-rheumatic drugs (DMARDs) in people with inflammatory arthritisVille Ponkilainen, Teemu V Karjalainen, Ilari Kuitunen, et al.
The Cochrane Database of Systematic Reviews|July 13, 2026
Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysisJocelyn Thomas, Mohammed Mujaab Kamso, Samuel L Whittle, et al.
The Cochrane Database of Systematic Reviews|March 25, 2025
Audit and feedback: effects on professional practiceNoah Ivers, Sharlini Yogasingam, Meagan Lacroix, et al.
The Cochrane Database of Systematic Reviews|June 22, 2026
Audit and feedback: effects on professional practiceNoah Ivers, Sharlini Yogasingam, Meagan Lacroix, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Cochrane Database of Systematic Reviews|October 29, 2024
Improving adverse drug event reporting by healthcare professionalsGloria Shalviri, Niayesh Mohebbi, Fariba Mirbaha, et al.
The Cochrane Database of Systematic Reviews|September 30, 2025
Dose reduction and discontinuation of conventional synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with rheumatoid arthritis or psoriatic arthritis in remission or low disease activityHuai Leng Pisaniello, Samuel L Whittle, Renea V Johnston, et al.
The Cochrane Database of Systematic Reviews|March 1, 2024
Models for delivery and co-ordination of primary or secondary health care (or both) to older adults living in aged care facilitiesPolina Putrik, Liesl Grobler, Aislinn Lalor, et al.
The Cochrane Database of Systematic Reviews|December 16, 2024
Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with psoriatic arthritis in remission or low disease activityHelen Ramsay, Renea V Johnston, Sheila Cyril, et al.
The Cochrane Database of Systematic Reviews|April 22, 2025
Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancerLiesl Grobler, Denise O'Connor, Danny Rischin, et al.
The Spine Journal : Official Journal of the North American Spine Society|July 10, 2025
Agreement between high-quality clinical practice guidelines in their treatment recommendations for low back pain: a systematic reviewBayden J McKenzie, Romi Haas, Giovanni E Ferreira, et al.
The Cochrane Database of Systematic Reviews|May 20, 2026
Perioperative use of disease-modifying anti-rheumatic drugs (DMARDs) in people with inflammatory arthritisVille Ponkilainen, Teemu V Karjalainen, Ilari Kuitunen, et al.
The Cochrane Database of Systematic Reviews|July 13, 2026
Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysisJocelyn Thomas, Mohammed Mujaab Kamso, Samuel L Whittle, et al.
The Cochrane Database of Systematic Reviews|March 25, 2025
Audit and feedback: effects on professional practiceNoah Ivers, Sharlini Yogasingam, Meagan Lacroix, et al.
The Cochrane Database of Systematic Reviews|June 22, 2026
Audit and feedback: effects on professional practiceNoah Ivers, Sharlini Yogasingam, Meagan Lacroix, et al.
Pageof 2